Supplementary material 17 to: Electronic cigarettes for smoking cessation

Lindson N, Livingstone-Banks J, Butler AR, McRobbie H, Bullen CR, Hajek P, Wu AD, Begh R, Theodoulou A, Ma C, Notley C, Rigotti NA, Turner T, Fanshawe T, Hartmann-Boyce J
https://doi.org/10.1002/14651858.CD010216.pub11

The material in this section has been supplied by the author(s) for publication under a Licence for Publication and the author(s) are solely responsible for the material. Cochrane has reviewed this material, but Cochrane has not copyedited, formatted or proofread. Cochrane accordingly gives no representations or warranties of any kind in relation to, and accepts no liability for any reliance on or use of, such material.

Back to top

Product use at 6+ months for data not contributing to meta-analyses

Study ID

Comparison

Time point (months)

Data

Between group difference (↑

Higher product use in intervention arm; ↔ equivocal; ↓ lower product use in intervention arm)

Walker 2020

Nicotine EC + nicotine patch v. non-nicotine EC + nicotine patch

Nicotine EC + nicotine patch v. nicotine patch

6 months

In the nicotine EC+ patch group (n = 317), 22% were using patches only, 45% were using EC only, and 11% were using both patch and EC, whereas in the non-nicotine EC + patch group (n = 308), 29% were still using patches, 36% were using EC only, and 13% were using both patches and EC.

In the nicotine EC+ patch group (n = 317), 22% were using patches only, 45% were using EC only, and 11% were using both patch and EC, whereas 40% of the patches-only arm (n = 52) were still using patches.

Patch only ↓; EC only ↑; Patch & EC ↓

Patch only ↓